14 analysts have shared their evaluations of JPMorgan Chase JPM during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 7 | 4 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 3 | 2 | 0 | 0 |
3M Ago | 2 | 3 | 2 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $211.29, a high estimate of $228.00, and a low estimate of $185.00. Observing a 1.48% increase, the current average has risen from the previous average price target of $208.21.
Diving into Analyst Ratings: An In-Depth Exploration
A clear picture of JPMorgan Chase's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Glenn Schorr | Evercore ISI Group | Maintains | Outperform | $210.00 | $210.00 |
Gerard Cassidy | RBC Capital | Maintains | Outperform | $211.00 | $211.00 |
Erika Najarian | UBS | Raises | Buy | $224.00 | $219.00 |
Betsy Graseck | Morgan Stanley | Lowers | Overweight | $214.00 | $216.00 |
Scott Siefers | Piper Sandler | Raises | Overweight | $220.00 | $215.00 |
David George | Baird | Raises | Neutral | $185.00 | $175.00 |
David Konrad | Keefe, Bruyette & Woods | Raises | Market Perform | $209.00 | $203.00 |
Erika Najarian | UBS | Lowers | Buy | $219.00 | $226.00 |
Betsy Graseck | Morgan Stanley | Lowers | Overweight | $216.00 | $221.00 |
Scott Siefers | Piper Sandler | Lowers | Overweight | $215.00 | $220.00 |
James Fotheringham | BMO Capital | Lowers | Market Perform | $195.00 | $196.00 |
Chris Kotowski | Oppenheimer | Lowers | Outperform | $217.00 | $219.00 |
Ken Usdin | Jefferies | Raises | Buy | $228.00 | $202.00 |
David Konrad | Keefe, Bruyette & Woods | Raises | Market Perform | $195.00 | $182.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to JPMorgan Chase. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of JPMorgan Chase compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of JPMorgan Chase's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on JPMorgan Chase analyst ratings.
Delving into JPMorgan Chase's Background
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $3.9 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
Understanding the Numbers: JPMorgan Chase's Finances
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: JPMorgan Chase's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 9.28%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: JPMorgan Chase's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 30.88% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.26%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): JPMorgan Chase's ROA excels beyond industry benchmarks, reaching 0.32%. This signifies efficient management of assets and strong financial health.
Debt Management: JPMorgan Chase's debt-to-equity ratio is below the industry average at 1.44, reflecting a lower dependency on debt financing and a more conservative financial approach.
How Are Analyst Ratings Determined?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.